The expression of SRD5A1and SRD5A2 was negatively correlated with the HCC tumor stage, and the high expression of SRD5A3 was significantly positively associated with the high tumor stage (Figure 2(a)). Here, SRD5A2 is linked to hepatocellular carcinoma.